[go: up one dir, main page]

PL2800563T3 - Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form - Google Patents

Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form

Info

Publication number
PL2800563T3
PL2800563T3 PL13733671T PL13733671T PL2800563T3 PL 2800563 T3 PL2800563 T3 PL 2800563T3 PL 13733671 T PL13733671 T PL 13733671T PL 13733671 T PL13733671 T PL 13733671T PL 2800563 T3 PL2800563 T3 PL 2800563T3
Authority
PL
Poland
Prior art keywords
dpa
omega
fatty acids
free acid
polyunsaturated fatty
Prior art date
Application number
PL13733671T
Other languages
Polish (pl)
Inventor
Timothy J. Maines
Bernardus N.M. Machielse
Bharat M. Mehta
Gerald WISLER
Michael Davidson
Peter Ralph WOOD
Original Assignee
Omthera Pharmaceuticals Inc.
Chrysalis Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48744082&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2800563(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Omthera Pharmaceuticals Inc., Chrysalis Pharma Ag filed Critical Omthera Pharmaceuticals Inc.
Publication of PL2800563T3 publication Critical patent/PL2800563T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Materials For Photolithography (AREA)
  • Medicines Containing Plant Substances (AREA)
PL13733671T 2012-01-06 2013-01-04 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form PL2800563T3 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201261583796P 2012-01-06 2012-01-06
US201261664047P 2012-06-25 2012-06-25
US201261669940P 2012-07-10 2012-07-10
US201261680622P 2012-08-07 2012-08-07
US201261710517P 2012-10-05 2012-10-05
US201261713388P 2012-10-12 2012-10-12
EP13733671.5A EP2800563B1 (en) 2012-01-06 2013-01-04 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
PCT/US2013/020398 WO2013103902A1 (en) 2012-01-06 2013-01-04 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form

Publications (1)

Publication Number Publication Date
PL2800563T3 true PL2800563T3 (en) 2018-12-31

Family

ID=48744082

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13733671T PL2800563T3 (en) 2012-01-06 2013-01-04 Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form

Country Status (35)

Country Link
US (5) US20150004224A1 (en)
EP (2) EP3348262A1 (en)
JP (3) JP6399655B2 (en)
KR (2) KR102153143B1 (en)
CN (3) CN107050457A (en)
BR (1) BR112014016788A8 (en)
CA (1) CA2860512C (en)
CL (1) CL2014001803A1 (en)
CO (1) CO7061070A2 (en)
CY (1) CY1120663T1 (en)
DK (1) DK2800563T3 (en)
DO (1) DOP2014000159A (en)
EC (1) ECSP14012527A (en)
ES (1) ES2685703T3 (en)
HK (1) HK1251457A1 (en)
HR (1) HRP20181418T1 (en)
HU (1) HUE039659T2 (en)
IL (3) IL233517A (en)
IN (1) IN2014DN06125A (en)
LT (1) LT2800563T (en)
MX (1) MX358319B (en)
MY (1) MY165048A (en)
NZ (1) NZ626699A (en)
PE (1) PE20142459A1 (en)
PH (2) PH12014501553A1 (en)
PL (1) PL2800563T3 (en)
PT (1) PT2800563T (en)
RS (1) RS57777B1 (en)
RU (2) RU2018116572A (en)
SG (2) SG11201403805WA (en)
SI (1) SI2800563T1 (en)
SM (1) SMT201800519T1 (en)
UA (1) UA114615C2 (en)
WO (1) WO2013103902A1 (en)
ZA (1) ZA201405765B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
PE20142459A1 (en) 2012-01-06 2015-01-23 Omthera Pharmaceuticals Inc DPA-ENRICHED COMPOSITIONS OF POLYINSATURATED OMEGA 3 FATTY ACIDS IN FREE ACID FORM
KR20150028233A (en) 2012-05-07 2015-03-13 옴테라 파마슈티칼스, 인크. Compositions of statins and omega-3 fatty acids
CA2916208A1 (en) 2012-06-17 2013-12-27 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
GB201216385D0 (en) * 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
EP2911657A4 (en) * 2012-10-23 2016-08-03 Univ Deakin PROCESS FOR REDUCING TRIGLYCERIDES
US10123986B2 (en) 2012-12-24 2018-11-13 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
US9629820B2 (en) 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations
GB201301626D0 (en) 2013-01-30 2013-03-13 Dignity Sciences Ltd Composition comprising 15-OHEPA and methods of using the same
US9452151B2 (en) * 2013-02-06 2016-09-27 Amarin Pharmaceuticals Ireland Limited Methods of reducing apolipoprotein C-III
WO2015011724A2 (en) 2013-07-22 2015-01-29 Kms Health Center Pvt Ltd A novel omega -3 fatty acid composition with a plant extract
WO2015024055A1 (en) * 2013-08-20 2015-02-26 Deakin University Separation of omega-3 fatty acids
EP3062785B1 (en) 2013-10-30 2020-07-22 Patheon Softgels Inc. Enteric soft capsules comprising polyunsaturated fatty acids
CN109232278A (en) 2013-11-15 2019-01-18 Ds生物制药有限公司 The pharmaceutically acceptable salt of how unsaturated hydroxy fatty acid
EP3140316A1 (en) 2014-05-05 2017-03-15 Thetis Pharmaceuticals LLC Compositions and methods relating to ionic salts of peptides
CN107072959A (en) * 2014-06-04 2017-08-18 尊严科学有限公司 Medical composition comprising two high acid and gamma-linolenics (DGLA) with and application thereof
US9242008B2 (en) 2014-06-18 2016-01-26 Thetis Pharmaceuticals Llc Mineral amino-acid complexes of fatty acids
EP3157936B1 (en) 2014-06-18 2018-10-17 Thetis Pharmaceuticals LLC Mineral amino-acid complexes of active agents
US9895333B2 (en) 2014-06-26 2018-02-20 Patheon Softgels Inc. Enhanced bioavailability of polyunsaturated fatty acids
WO2016069446A1 (en) * 2014-10-28 2016-05-06 Omthera Pharmaceuticals Inc Methods for modulating plasma levels of lipoproteins
WO2016073335A1 (en) * 2014-11-05 2016-05-12 Omthera Pharmaceuticals Inc. Methods of treatment
US20160192126A1 (en) * 2014-12-31 2016-06-30 Silver Spring Networks, Inc. System and method for tracking a device
MA41611A (en) * 2015-02-23 2018-01-02 Omthera Pharmaceuticals Inc MILLI-CAPSULE PREPARATIONS CONTAINING FREE POLYINSATURATED FATTY ACIDS
WO2016178066A1 (en) * 2015-05-01 2016-11-10 Mohan M Alapati Compositions and methods for the treatment of hyperglycemia and metabolic syndrome
EP3294282A1 (en) 2015-05-13 2018-03-21 DS Biopharma Limited Compositions comprising 15-oxo-epa or 15-oxo-dgla and methods of making and using same
EP3861995A1 (en) 2015-07-21 2021-08-11 Affimune Limited Compositions comprising 15-hepe for use in treating or preventing neurologic disease
JP2018537513A (en) 2015-12-18 2018-12-20 アフィミューン リミテッド Compositions containing 15-HEPE and methods of use thereof
US10263794B2 (en) * 2016-05-19 2019-04-16 Linear Technology Corporation Maintain power signature controller at power interface of PoE or PoDL system
CA3026264A1 (en) 2016-06-03 2017-12-07 Thetis Pharmaceuticals Llc Compositions and methods relating to salts of specialized pro-resolving mediators
GB201611920D0 (en) 2016-07-08 2016-08-24 Astrazeneca Ab Pharmaceutical compositions
CN119950727A (en) 2017-05-16 2025-05-09 能力制药公司 Drug combinations used to treat cancer
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh Enteric coated solid dosage form comprising omega-3 fatty acid amino acid salts
EP3668498A1 (en) 2017-08-15 2020-06-24 Evonik Operations GmbH Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
EP3586642A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Ala enriched polyunsaturated fatty acid compositions
EP3586640A1 (en) 2018-06-21 2020-01-01 Nuseed Pty Ltd Dha enriched polyunsaturated fatty acid compositions
KR20220044542A (en) 2019-08-08 2022-04-08 에보니크 오퍼레이션즈 게엠베하 Downstream Process for Preparation of Polyunsaturated Fatty Acid Salts
WO2021023857A1 (en) 2019-08-08 2021-02-11 Evonik Operations Gmbh Solubility enhancement of poorly soluble actives
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5735512A (en) 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
US4377526A (en) 1981-05-15 1983-03-22 Nippon Suisan Kaisha, Ltd. Method of purifying eicosapentaenoic acid and its esters
BR8803255A (en) 1981-11-10 1990-02-06 Century Lab Inc PROCESS OF EXTRACTION AND PURIFICATION OF POLYUNSATURATED FATTY ACIDS FROM NATURAL SOURCES
JPS59157018A (en) 1983-02-27 1984-09-06 Furointo Sangyo Kk Novel oil-containing coated capsule pperaration
JPS59225115A (en) 1983-06-06 1984-12-18 Ota Seiyaku Kk Microcapsule containing highly unsaturated long-chain fatty acid obtained from blue fish
JPS61126016A (en) 1984-11-22 1986-06-13 Toagosei Chem Ind Co Ltd Microcapsule containing unsaturated fatty acid
EP0347509A1 (en) 1988-06-21 1989-12-27 Century Laboratories Inc. A process of extraction and purification of polyunsaturated fatty acids from natural sources
CH669208A5 (en) 1986-12-17 1989-02-28 Nestle Sa PROCESS OF CONTINUOUS FRACTIONATION OF A MIXTURE OF FATTY ACIDS.
US5243046A (en) 1986-12-17 1993-09-07 Nestec S.A. Process for the continuous fractionation of a mixture of fatty acids
EP0289204B1 (en) 1987-04-27 1991-07-17 Efamol Holdings Plc Lithium salt-containing pharmaceutical compositions
IT1205043B (en) 1987-05-28 1989-03-10 Innova Di Ridolfi Flora & C S PROCEDURE FOR THE EXTRACTION OF POLYUNSATURATED FATTY ACID ESTERS FROM FISH OILS AND PHARMACEUTICAL AND DIETARY COMPOSITIONS CONTAINING SUCH ESTERS
ZA885473B (en) 1987-08-07 1989-03-29 Century Lab Inc Free fatty acids for treatment of diabetes mellitus
US4843095A (en) 1987-08-07 1989-06-27 Century Laboratories, Inc. Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis
GB8819110D0 (en) 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
GB2223943A (en) 1988-10-21 1990-04-25 Tillotts Pharma Ag Oral disage forms of omega-3 polyunsaturated acids
NL9201438A (en) 1992-08-11 1994-03-01 Prospa Bv Novel pharmaceutical compositions comprising esters of omega-3 polyunsaturated acids and their use in the topical treatment of ailments.
CA2151820C (en) 1993-01-15 2000-11-28 Stephen Joseph Demichele Structured lipids
ATE147776T1 (en) 1993-04-29 1997-02-15 Norsk Hydro As METHOD FOR THE CHROMATOGRAPHIC FRACTIONATION OF FATTY ACIDS AND THEIR DERIVATIVES
JPH0753356A (en) 1993-08-16 1995-02-28 Morishita Jintan Kk Seamless capsule containing oxidizable oily substance and method for producing the same
US5767156A (en) 1993-10-06 1998-06-16 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
IT1264987B1 (en) 1993-12-14 1996-10-17 Prospa Bv SALTS OF A POLYUNSATURATED FATTY ACID AND PHARMACEUTICAL FORMULATIONS THAT CONTAIN THEM
US5494684A (en) 1994-02-23 1996-02-27 Bar-Ilan University Plant protection from infection by Phytophthora infestans using fish oil
GB9404483D0 (en) 1994-03-08 1994-04-20 Norsk Hydro As Refining marine oil compositions
RU2127115C1 (en) 1994-03-28 1999-03-10 Владимир Константинович Гаврисюк Polyunsaturated fatty acid mixture "omega-3"
ES2131129T3 (en) 1994-05-09 1999-07-16 Nestle Sa PROCEDURE FOR THE PREPARATION OF A CONCENTRATE OF ESTERS OF POLYINSATURATED FATTY ACIDS.
IT1274734B (en) 1994-08-25 1997-07-24 Prospa Bv PHARMACEUTICAL COMPOSITIONS CONTAINING POLYUNSATURATED FATTY ACIDS, THEIR ESTERS OR SALTS, WITH VITAMINS OR ANTIOXIDANT PROVITAMINS
JPH08100191A (en) * 1994-09-30 1996-04-16 Nisshin Flour Milling Co Ltd Purification of highly unsaturated fatty acid or ester thereof
NL9401743A (en) 1994-10-20 1996-06-03 Prospa Bv Salts of amino alcohols and pharmaceutical formulations containing them.
GB2300807B (en) 1995-05-15 1999-08-18 Tillotts Pharma Ag Oral dosage forms of omega-3 polynunsaturated acids for the treatment of inflammatory bowel disease
GB9509764D0 (en) 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
WO1997039759A2 (en) 1996-04-24 1997-10-30 Brigham And Women's Hospital Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
JPH1095744A (en) * 1996-09-20 1998-04-14 Nof Corp Production of highly unsaturated aliphatic acid or its alkyl ester
PT843972E (en) * 1996-11-20 2002-12-31 Nutricia Nv NUTRITIVE COMPOSITION THAT INCLUDES FATS FOR THE TREATMENT OF METABOLIC SYNDROME
GB9701705D0 (en) 1997-01-28 1997-03-19 Norsk Hydro As Purifying polyunsatured fatty acid glycerides
AU6184298A (en) 1997-02-25 1998-09-09 Genzyme Transgenics Corporation Transgenically produced non-secreted proteins
US6852870B2 (en) 1999-03-22 2005-02-08 Andrew Stoll Omega-3 fatty acids in the treatment of depression
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
NO312973B1 (en) 1999-02-17 2002-07-22 Norsk Hydro As Lipase-catalyzed esterification of marine oils
US7112609B2 (en) 1999-06-01 2006-09-26 Drugtech Corporation Nutritional supplements
JP2001054396A (en) 1999-06-08 2001-02-27 Nippon Suisan Kaisha Ltd Method for producing fats and oils containing highly unsaturated fatty acids by lipase
WO2001006983A2 (en) 1999-07-22 2001-02-01 Incell Corporation, Llc Fatty acids to minimize cancer therapy side effects
NO310113B1 (en) 1999-08-11 2001-05-21 Norsk Hydro As Process for the recovery of polyunsaturated fatty acids from urea complexes
EP1211955A1 (en) 1999-08-30 2002-06-12 Ocean Nutrition Canada Ltd. A nutritional supplement for lowering serum triglyceride and cholesterol levels
HK1047054B (en) 1999-08-31 2005-04-15 Chugai Seiyaku Kabushiki Kaisha Soft capsules
EP1106072B1 (en) 1999-12-10 2005-11-30 Loders Croklaan B.V. Palmitoleic acid and its use in foods
AU2634101A (en) 2000-01-06 2001-07-16 Martek Biosciences Corporation Therapeutic preparations of highly unsaturated fatty acids
DE60022987T2 (en) 2000-05-22 2006-10-19 Pro Aparts - Investimentos E Consultoria Lda., Funchal Fatty acid composition containing at least 80% by weight of EPA and DHA
GB0016045D0 (en) 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
GB0016452D0 (en) 2000-07-04 2000-08-23 Kilgowan Limited Vitamin K and essential fatty acids
EP1178103A1 (en) 2000-08-02 2002-02-06 Dsm N.V. Purifying crude pufa oils
KR20010008387A (en) 2000-11-30 2001-02-05 이성권 Method for producing highly pure unsaturated fatty acid using crystallization
US20040241249A1 (en) 2001-06-18 2004-12-02 Tina Sampalis Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases arthritis, skin cancer diabetes, premenstrual syndrome and transdermal transport
CN1197564C (en) * 2001-09-30 2005-04-20 中国药品生物制品检定所 Application of fur seal oil in preparation of medicine for treating lipometabolism disorder (high blood fat)
ITMI20012384A1 (en) 2001-11-12 2003-05-12 Quatex Nv USE OF POLYUNSATURATED FATTY ACIDS FOR THE PRIMARY PREVENTION OF MAJOR CARDIOVASCULAR EVENTS
GB2385852A (en) 2002-02-27 2003-09-03 Rothamsted Ex Station Delta 6-desaturases from Primulaceae
AU2003218319A1 (en) 2002-03-22 2003-10-13 Doc's Guide, Inc. Multivitamin and mineral nutritional supplement
DE10214005A1 (en) 2002-03-27 2003-10-09 Volker Bartz Orally administered dietetic, nutritional supplement or medicament composition, useful as hypolipemic agent, comprising mixture of pectin and/or guar powder with eicosapentaenoic and docosahexaenoic acids
ITMI20020731A1 (en) 2002-04-08 2003-10-08 Ibsa Inst Biochimique Sa PHARMACEUTICAL COMPOSITIONS FOR ACETYLSALICYLIC ACID AND OMEGA-3 OILS
NZ518504A (en) 2002-04-22 2005-05-27 Ind Res Ltd Use of near-critical fluids in the separation of saturated and mono-unsaturated fatty acids from urea-containing solutions
EP2295529B2 (en) 2002-07-11 2022-05-18 Basf As Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
SE0202188D0 (en) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
NO319194B1 (en) 2002-11-14 2005-06-27 Pronova Biocare As Lipase-catalyzed esterification process of marine oils
US8017651B2 (en) 2002-11-22 2011-09-13 Bionexus, Ltd. Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia
AU2003288606A1 (en) 2002-12-20 2004-07-14 Pronova Biocare As Use of a fatty acid composition for treatment of male infertility
WO2004098311A1 (en) 2003-05-05 2004-11-18 Denofa As Fish oils with an altered fatty acid profile, method of producing same and their use
US6846942B2 (en) 2003-05-20 2005-01-25 David Rubin Method for preparing pure EPA and pure DHA
PT1645617E (en) 2003-07-09 2010-05-03 J Oil Mills Inc Antioxidant fat or oil composition containing long-chain highly unsaturated fatty acid
US7759507B2 (en) 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
ITMI20032247A1 (en) 2003-11-19 2005-05-20 Tiberio Bruzzese INTERACTION OF POLAR DERIVATIVES OF COMPOUNDS INSATURATED WITH INORGANIC SUBSTRATES
SE0303513D0 (en) 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and any or any combination thereof
GB0403247D0 (en) * 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
GB0413729D0 (en) 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
GB0413730D0 (en) 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
US20070265341A1 (en) 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
WO2006004438A1 (en) 2004-07-05 2006-01-12 Otago Innovation Limited Hoki fish liver oil, fractions thereof and therapeutic uses
RU2394598C2 (en) 2004-07-19 2010-07-20 Тиа Медика Ас Composition containing protein material and compounds which contain unoxidisable structural elements of fatty acids
EP1784223A2 (en) 2004-07-19 2007-05-16 Thia Medica AS Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities
WO2007130714A1 (en) 2006-02-01 2007-11-15 Transform Pharmaceuticals, Inc. Novel statin pharmaceutical compositions and related methods of treatment
WO2007130713A1 (en) 2006-02-01 2007-11-15 Transform Pharmaceuticals, Inc. Novel fenofibrate formulations and related methods of treatment
CA2576196A1 (en) 2004-08-06 2006-02-16 Transform Pharmaceuticals, Inc. Novel statin pharmaceutical compositions and related methods of treatment
AU2005271407A1 (en) 2004-08-06 2006-02-16 Transform Pharmaceuticals, Inc. Novel fenofibrate formulations and related methods of treatment
EP1791544A4 (en) 2004-09-08 2007-09-12 Chelsea Therapeutics Inc DERIVATIVES OF QUINAZOLIN AS METABOLICALLY INERT ANTIFOLIC
WO2006036967A1 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Solubilizing a drug for use in a coating
US20070191467A1 (en) * 2004-12-06 2007-08-16 Reliant Pharmaceutical, Inc. Statin and omega-3 fatty acids for lipid therapy
DE102004062141A1 (en) 2004-12-23 2006-07-06 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Process for the preparation of a crude oil from mixtures of microorganisms and plants, the oil thus produced and the specific uses of the thus prepared and optionally additionally refined oil
EP1845999A4 (en) 2005-01-24 2010-09-22 Pronova Biocare As Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
EP1858352B1 (en) 2005-02-18 2013-06-05 Delante Health AS A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base
EP1861087A4 (en) 2005-03-08 2010-02-10 Reliant Pharmaceuticals Inc TREATMENT WITH STATIN AND OMEGA 3 FATTY ACIDS AND CORRESPONDING COMBINATION PRODUCT
DE102005013779A1 (en) 2005-03-22 2006-09-28 Basf Plant Science Gmbh Process for the preparation of polyunsaturated C20 and C22 fatty acids having at least four double bonds in transgenic plants
WO2006102896A2 (en) 2005-03-29 2006-10-05 Aalborg Universitet A process to concentrate ω3-pufa from fish oil by selective hydrolysis using cutinase immobilized on zeolite nay
KR100539357B1 (en) 2005-04-11 2005-12-28 동부한농화학 주식회사 A process for the preparation of unsaturated fatty acid
WO2006117664A1 (en) 2005-05-04 2006-11-09 Pronova Biopharma Norge As New dha derivatives and their use as medicaments
US7485323B2 (en) 2005-05-31 2009-02-03 Gelita Ag Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions
EP2630869B1 (en) 2005-07-01 2016-12-14 DSM IP Assets B.V. Polyunsaturated fatty acid-containing oil product and uses and production thereof
US20070020340A1 (en) 2005-07-25 2007-01-25 David Rubin Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension
EP1922065A4 (en) 2005-08-04 2009-11-11 Transform Pharmaceuticals Inc NOVEL FORMULATIONS CONTAINING FENOFIBRATE AND STATIN AND ASSOCIATED TREATMENT METHODS
ITMI20051560A1 (en) 2005-08-10 2007-02-11 Tiberio Bruzzese COMPOSITION OF N-3 FATTY ACIDS WITH HIGH CONCENTRATION OF EPA AND E-O DHA AND CONTAINING N-6 FATTY ACIDS
US20070134493A1 (en) 2005-12-08 2007-06-14 Kanji Meghpara Compositions and capsules with stable hydrophilic layers
EP1968567B1 (en) 2005-12-20 2014-06-18 Cenestra, Llc Omega 3 fatty acid formulations
FR2896172B1 (en) 2006-01-17 2008-10-10 Polaris Soc Par Actions Simpli NOVEL METHOD FOR STABILIZING POLYUNSATURATED FATTY ACIDS AND THE COMPOSITIONS THUS OBTAINED
AR059376A1 (en) 2006-02-21 2008-03-26 Basf Plant Science Gmbh PROCEDURE FOR THE PRODUCTION OF POLYINSATURATED FATTY ACIDS
DE102006008030A1 (en) 2006-02-21 2007-08-23 Basf Plant Science Gmbh Preparation of polyunsaturated fatty acids in transgenic plants, useful e.g. for reducing risk of hypertension and heart disease, includes expressing a codon-optimized sequence for delta5-elongase
WO2007128801A1 (en) 2006-05-08 2007-11-15 Novartis Ag Combination of organic compounds
US8003813B2 (en) 2006-06-27 2011-08-23 Pos Pilot Plant Corporation Process for separating saturated and unsaturated fatty acids
KR100684641B1 (en) 2006-07-25 2007-02-22 주식회사 일신웰스 Fat and oil compositions, foods and supplements containing same
WO2008012329A2 (en) 2006-07-28 2008-01-31 V. Mane Fils Seamless capsules containing high amounts of polyunsaturated fatty acids and a flavouring component
KR100758664B1 (en) 2006-08-16 2007-09-13 (주)케비젠 Method for preparing unsaturated fatty acid-containing microcapsules, microcapsules prepared by the method and products containing the same
CN101194913A (en) * 2006-12-05 2008-06-11 张金生 Natural seal oil compression biological preparation for treating hyperlipidemia and technique of preparing the same
EP2124905B1 (en) 2007-01-10 2016-09-07 DSM Nutritional Products AG Microcapsules including pea protein
JP2010515773A (en) 2007-01-16 2010-05-13 リライアント・ファーマシューティカルズ・インコーポレイテッド Treatment with non-steroidal anti-inflammatory drugs and omega-3 fatty acids and combination products thereof
US20110190389A1 (en) 2007-02-20 2011-08-04 Linda Arterburn Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
WO2008113177A1 (en) 2007-03-20 2008-09-25 Centre De Recherche Sur Les Biotechnologies Marines Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
CA2685272A1 (en) 2007-04-26 2008-11-06 Patrick Adlercreutz A polyunsaturated fatty acid (pufa) enriched marine oil comprising eicosapentaenoic acid (epa) and docosahexaenoic acid (dha), and a process of production thereof
US20090011012A1 (en) 2007-07-06 2009-01-08 Baum Seth J Fatty acid compositions and methods of use
CL2008002020A1 (en) 2007-07-12 2008-11-14 Ocean Nutrition Canada Ltd Method of modifying an oil, which comprises hydrolyzing glycerides with a solution of thermomyces lanuginosus lipase, separating the saturated fatty acid fraction from the hydrolyzed glyceride fraction and esterifying the hydrolyzed glycerides in the presence of candida antarctica lipase b; and oil composition.
CA2694054C (en) 2007-07-25 2015-11-17 Epax As Omega-3 fatty acid fortified composition
US9556401B2 (en) 2007-07-30 2017-01-31 Nippon Suisan Kaisha, Ltd. Method for producing EPA-enriched oil and DHA-enriched oil
WO2009020406A1 (en) 2007-08-07 2009-02-12 Granate Seed Limited Methods of making lipid substances, lipid substances made thereby and uses thereof
WO2009028457A1 (en) 2007-08-29 2009-03-05 Shinshu University Therapeutic agent for nonalcoholic steatohepatitis
DE102007055344A1 (en) 2007-11-19 2009-05-20 K. D. Pharma Bexbach Gmbh New use of omega-3 fatty acid (s)
EP2229939A4 (en) 2008-01-10 2011-04-27 Takeda Pharmaceutical PREPARATION OF CAPSULES
US20090182049A1 (en) 2008-01-16 2009-07-16 Joar Arild Opheim Pharmaceutical Composition and Method for Treating Hypertriglyceridemia and Hypercholesterolemia in Humans
JP2011522913A (en) 2008-05-15 2011-08-04 プロノヴァ バイオファーマ ノルゲ アーエス Krill oil processing method
PL2334295T3 (en) 2008-09-02 2017-12-29 Amarin Pharmaceuticals Ltd Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same
US20100062057A1 (en) 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
PT2337857T (en) 2008-10-02 2017-06-02 Gonzalez Ramon Nieves Microalgae extract containing 3 -polyunsaturated fatty acids and method for extracting oil from micro-organisms
PL2349250T3 (en) 2008-10-31 2017-09-29 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
SI2596786T1 (en) 2009-02-10 2020-03-31 Amarin Pharmaceuticals Ireland Limited, Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia
CN101822651A (en) * 2009-03-05 2010-09-08 Dpa工业公司 Chewable capsule and preparation method thereof
WO2010119319A1 (en) 2009-03-09 2010-10-21 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
MX2011010821A (en) 2009-04-17 2012-01-20 Cela Vista Pharmaceuticals Ltd COMPOSITIONS RICH IN OMEGA-3 FATTY ACIDS WITH LOW CONTENT IN FITANIC ACID.
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
CN104856985B (en) 2009-04-29 2019-01-04 阿马里纳制药爱尔兰有限公司 Stable pharmaceutical composition and the method using it
BRPI1009920A2 (en) 2009-05-01 2016-03-15 Micropharma Ltd bacterial compositions for prophylaxine and treatment of degenerative disease.
CA3026006C (en) 2009-06-15 2021-09-07 Amarin Pharmaceuticals Ireland Limited Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
US8304551B2 (en) 2009-09-01 2012-11-06 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
WO2011038122A1 (en) 2009-09-23 2011-03-31 Amarin Corporation Plc Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
CN102724972A (en) 2009-10-23 2012-10-10 普罗诺瓦生物医药挪威公司 Coated capsules and coated tablets of fatty acid oil blend
RU2009145010A (en) 2009-12-04 2011-06-20 Общество с ограниченной ответственностью (ООО) "Аббифарм" (RU) COMPOSITION OMEGA-3 AND OMEGA-6 POLYUNSATURATED FATTY ACIDS
WO2011095284A1 (en) 2010-02-02 2011-08-11 Cognis Ip Management Gmbh Enrichment of polyunsaturated fatty acids
GB201006204D0 (en) 2010-04-14 2010-06-02 Ayanda As Composition
AU2011242843A1 (en) 2010-04-22 2012-09-27 E. I. Du Pont De Nemours And Company Method for obtaining polyunsaturated fatty acid-containing compositions from microbial biomass
CA2803477C (en) 2010-06-25 2019-04-30 Epax As Process for separating polyunsaturated fatty acids from long chain unsaturated or less saturated fatty acids
JP2013537185A (en) 2010-09-08 2013-09-30 プロノヴァ・バイオファーマ・ノルゲ・アーエス Composition comprising a fatty acid oil mixture comprising EPA and DHA in free acid form, a surfactant and a statin
CN103221524B (en) 2010-09-24 2021-01-01 普罗诺瓦生物医药挪威公司 Method for concentrating omega-3 fatty acids
WO2012083034A1 (en) 2010-12-15 2012-06-21 Louis Sanfilippo Modulation of neurotrophic factors by omega-3 fatty acid formulations
WO2012087153A1 (en) 2010-12-23 2012-06-28 Marine Bioproducts As Enrichment of marine oils with omega-3 polyunsaturated fatty acids by lipase-catalysed hydrolysis
EP2476425B1 (en) 2011-01-14 2014-03-19 Visiotact Pharma Composition comprising OPC and Omega-3 for preventing and/or inhibiting the development of diabetic retinopathy
CA2827585A1 (en) 2011-02-16 2012-08-23 Pivotal Therapeutics, Inc. Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases
JP2014505731A (en) * 2011-02-16 2014-03-06 ピヴォタル セラピューティクス インコーポレイテッド Ω3 formulation containing EPA, DHA and DPA for treating risk factors for cardiovascular disease
WO2012112520A1 (en) 2011-02-16 2012-08-23 Pivotal Therapeutics, Inc. A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
JP2014505729A (en) * 2011-02-16 2014-03-06 ピヴォタル セラピューティクス インコーポレイテッド Cholesterol absorption inhibitors (azetidinone) and omega-3 fatty acids (EPA, DHA, DPA) for the reduction of cholesterol and cardiovascular events
WO2012112517A1 (en) * 2011-02-16 2012-08-23 Pivotal Therapeutics, Inc. Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd)
WO2012112902A1 (en) 2011-02-18 2012-08-23 Martek Biosciences Corporation Methods of preparing free polyunsaturated fatty acids
US20140051877A1 (en) 2011-04-28 2014-02-20 Nandakishore Jeevanrao Duragkar Eicosapentaenoic acid (epa) as polyunsaturated free fatty acid in its directly compressible powder form and process of isolation thereof
CN102311868B (en) 2011-04-29 2017-05-24 塞拉斯有限责任公司 Method for extracting krill oil rich in phospholipids and neutral lipid without using solvent
US8697676B2 (en) 2011-06-15 2014-04-15 Ronald E Rosedale Omega-3 fatty acid nutriceutical composition and optimization method
US20130095179A1 (en) 2011-09-15 2013-04-18 Omthera Pharmaceuticals, Inc. Methods and compositions for treating, reversing, inhibiting or preventing resistance to antiplatelet therapy
US20140316003A1 (en) 2011-10-21 2014-10-23 Omthera Pharmaceuticals, Inc. Methods and compositions for treating or preventing attention deficit hyperactivity disorder
US9861605B2 (en) 2011-10-24 2018-01-09 Stable Solutions Llc Enriched injectable emulsion containing selected fatty acid triglycerides
PE20142459A1 (en) 2012-01-06 2015-01-23 Omthera Pharmaceuticals Inc DPA-ENRICHED COMPOSITIONS OF POLYINSATURATED OMEGA 3 FATTY ACIDS IN FREE ACID FORM
HK1204978A1 (en) 2012-03-30 2015-12-11 桑茨利奥&孔帕尼股份有限公司 Omega-3 fatty acid ester compositions
KR20150028233A (en) 2012-05-07 2015-03-13 옴테라 파마슈티칼스, 인크. Compositions of statins and omega-3 fatty acids
US20140194512A1 (en) 2012-06-17 2014-07-10 Matinas Biopharma, Inc. Compositions comprising docosapentaenoic acid and methods of use
CA2916208A1 (en) 2012-06-17 2013-12-27 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
WO2016069446A1 (en) 2014-10-28 2016-05-06 Omthera Pharmaceuticals Inc Methods for modulating plasma levels of lipoproteins
WO2016073335A1 (en) 2014-11-05 2016-05-12 Omthera Pharmaceuticals Inc. Methods of treatment
WO2016130417A1 (en) 2015-02-11 2016-08-18 Omthera Pharmaceuticals Inc Omega-3 fatty acid prodrug compounds and uses thereof
MA41611A (en) 2015-02-23 2018-01-02 Omthera Pharmaceuticals Inc MILLI-CAPSULE PREPARATIONS CONTAINING FREE POLYINSATURATED FATTY ACIDS

Also Published As

Publication number Publication date
EP2800563B1 (en) 2018-07-11
SG10201701004RA (en) 2017-04-27
SMT201800519T1 (en) 2018-11-09
SI2800563T1 (en) 2018-11-30
RU2664429C2 (en) 2018-08-17
IN2014DN06125A (en) 2015-08-14
US20130177643A1 (en) 2013-07-11
CN107050457A (en) 2017-08-18
KR102153245B1 (en) 2020-09-08
HK1202073A1 (en) 2015-09-18
HRP20181418T1 (en) 2018-11-30
JP2017214392A (en) 2017-12-07
LT2800563T (en) 2018-10-25
SG11201403805WA (en) 2014-08-28
EP2800563A4 (en) 2015-06-17
PH12014501553B1 (en) 2014-10-08
KR20190119658A (en) 2019-10-22
CO7061070A2 (en) 2014-09-19
HK1251457A1 (en) 2019-02-01
ZA201405765B (en) 2016-05-25
MX358319B (en) 2018-08-14
IL233517A0 (en) 2014-08-31
DOP2014000159A (en) 2014-12-15
ECSP14012527A (en) 2015-09-30
US20150320715A1 (en) 2015-11-12
RS57777B1 (en) 2018-12-31
IL252084B (en) 2019-05-30
CN108524483A (en) 2018-09-14
US20150004224A1 (en) 2015-01-01
PH12014501553A1 (en) 2014-10-08
CY1120663T1 (en) 2019-12-11
CN104321055A (en) 2015-01-28
PE20142459A1 (en) 2015-01-23
US20190029985A1 (en) 2019-01-31
JP6399655B2 (en) 2018-10-03
US9050309B2 (en) 2015-06-09
PT2800563T (en) 2018-11-07
HUE039659T2 (en) 2019-01-28
IL252084A0 (en) 2017-07-31
CA2860512C (en) 2019-02-05
EP2800563A1 (en) 2014-11-12
UA114615C2 (en) 2017-07-10
KR20140135695A (en) 2014-11-26
MY165048A (en) 2018-02-28
US9050308B2 (en) 2015-06-09
IL266231B (en) 2020-08-31
RU2014128500A (en) 2016-02-27
JP2020045358A (en) 2020-03-26
CA2860512A1 (en) 2013-07-11
ES2685703T3 (en) 2018-10-10
JP6626857B2 (en) 2019-12-25
JP2015503590A (en) 2015-02-02
RU2018116572A (en) 2018-10-23
KR102153143B1 (en) 2020-09-08
MX2014008309A (en) 2015-04-13
EP3348262A1 (en) 2018-07-18
US20130209556A1 (en) 2013-08-15
IL266231A (en) 2019-06-30
NZ626699A (en) 2017-03-31
IL233517A (en) 2017-05-29
DK2800563T3 (en) 2018-10-08
PH12015502307A1 (en) 2017-04-10
CL2014001803A1 (en) 2015-01-30
PH12015502307B1 (en) 2017-04-10
US10117844B2 (en) 2018-11-06
BR112014016788A2 (en) 2017-06-13
WO2013103902A1 (en) 2013-07-11
BR112014016788A8 (en) 2017-07-04

Similar Documents

Publication Publication Date Title
IL266231A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
IL249821A0 (en) Omega-3 fatty acid ester compositions
EP2846779A4 (en) Compositions of statins and omega-3 fatty acids
IL228516A (en) Oral complex composition comprising omega-3 fatty acid ester and rosuvastatin
ZA201500015B (en) Production of long chain polyunsaturated fatty acids in plant cells
SG11201600337PA (en) SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
SG10201605082RA (en) Production Of Omega-Amino Fatty Acids
PL2734626T3 (en) Microbial oils enriched in polyunsaturated fatty acids
IL234757A0 (en) Tankmix additive concentrates containing triglyceride fatty acid esters and methods of use
IL234553A (en) Nutritional compositions including rrr-alpha tocopherol and polyunsaturated fatty acids
ZA201302760B (en) Novel omega-3 and omega-6 fatty acid compositions and uses thereof
ZA201403784B (en) Compositions comprising 20-carbon fatty acids and methods of making and using same
EP2668939A4 (en) COMPOSITION CONTAINING POLYUNSATURATED FATTY ACID
EP2931065A4 (en) Methods for preparing and compositions comprising plant-based omega-3 fatty acids
EP2845585A4 (en) Trehalose fatty acid ester composition
EP2928314A4 (en) Oxidatively-stabilized fats containing very long-chain omega-3 polyunsaturated fatty acids and uses thereof
EP2713725A4 (en) Oxidatively-stabilized fats containing very long-chain omega-3 polyunsaturated fatty acids
GB201222184D0 (en) Production of omega-3 long chain polyunsaturated fatty acids
GB201206483D0 (en) Production of omega-3 long chain polyunsaturated fatty acids
GB201217404D0 (en) Method to convert fatty acids
GB201208974D0 (en) Improvements in the manufacture of fatty acids